Abstract:BACKGROUND: Vaccine-induced antitumor CD8(superscript +) T-cell responses are believed to play an important role in increasing resistance to carcinoma. Research shows that after uptake of fusion proteins of heat-shock protein 70 (HSP70) with tumor associated antigen into antigen presenting cells, processing and representation of heat-shock protein-chaperoned peptides on MHC class I molecules, a CD8(superscript +) cytotoxic T lymphocyte response is initiated. OBJECTIVE: To construct and identify eukaryotic expression vector of melanoma antigen gene 3 MAGE-3-HSP70. DESIGN, TIME AND SETTING: A single sample observation was completed at Key Laboratory of Nano-biotechnology, National Ministry of Health from June to December 2008. MATERIALS: The eukaryotic vector pcDNA3.1 (-) was purchased from BD Company. The vector pINCY/MAGE-3 and pOTB7/HSP70 were purchased from Open Biosystems Company. DH5α were preserved at Key Laboratory of Nano-biotechnology, National Ministry of Public Health, China. METHODS: A pair of MAGE-3 primers containing Xho Ⅰ restriction site and HSP70 primers containing Kpn Ⅰ restriction site were designed. pINCY/MAGE-3 and pOTB7/HSP70 were used as template to amplify MAGE-3 and HSP70 gene by polymerase chain reaction (PCR). MAGE-3 upstream primer (containing Xho Ⅰ restriction site) and HSP70 downstream primer (containing Kpn Ⅰ restriction site) were used as template to amplify MAGE-3-HSP70 fusion gene fragments. The PCR products and empty plasmid pcDNA 3.1 (-) were digested by XhoⅠ and Kpn Ⅰ, ligated, then transformed competence E. coli DH5α. Positive clones were identified by restriction endonuclease digestion and sequencing. MAIN OUTCOME MEASURES: The identification of pcDNA3.1 (-)/MAGE-3-HSP70 fusion gene eukaryotic expression vector. RESULTS: Sequencing results showed that the MAGE-3 gene in the vector was in coincidence with the sequence registered in Gene Bank and the HSP70 had three synonymous mutations. CONCLUSION: MAGE-3-HSP70 fusion gene eukaryotic expression vector has been constructed successfully.

Construction and Identification of Recombinant Lentiviral Vector Containing Human MAGE-A3 Gene and Its Expression in Lung Cancer Cells

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Construction and Identification of Eukaryotic Expression Vector of MAGE-3-HSP70 Fusion Gene

Construction of Adenovirus Vector Carrying Murine Flt3 Ligand by Using Bacterial Homologous Recombination System and Its Expression in Hepatocellular Carcinoma

Construction of a Lentivirus Vector Expressing Three Reporter Genes and Its Experimental Study

Establishment of antigen MAGE-3 gene vaccine and primary study of its immune activity

Cloning and prokaryotic expression of tumor antigen MAGE-A9

Effects of Over-Expression of Melanoma Antigen Gene A3 on Human Hepatocellular Carcinoma Cell Lines

Construction and identification of recombinant lentivirus carrying human beta defensins-3 and connective tissue growth factor gene

Construction and Identification of Lentiviral Expression Vector Carry CEA Gene

Construction , expression and purification of recombinant HBcAg-MAGE-A 3 therapeutic cancer vaccine

Construction of Lentiviral Vector Over-Expressing MEG3 and Its Effect on XG-7 Cell Apoptosis

Construction and identification of the recombinant lentiviral vector containing human Runx3 gene

Construction and Expression of Recombinant Retroviral Vector Bearing Murine Aire Gene

Construction and Identification of Recombinant Retrovirus Vector Expressing Human Promyelocytic Leukemia Gene

Construction and Identification of a Recombinant Lentiviral Vector of RNA Interference of Lung Cancer Related Gene SLC35F2

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes

Construction, generation and identification of recombinant lentivirus vector with RBM3

Construction of recombinant plasmid vector containing human survivin-1 gene and expression in lung adenocarcinoma A549 cells

Construction of eukaryotic expression vector and package of lentivirus vector encoding prostate cancer antigen 3